| Literature DB >> 35116004 |
Yu-Xiang Yan1,2, Huan-Bo Xiao3, Ya-Ke Lu1,2, Yue Sun1, Shuo Wang1, Jing Dong4, Li-Juan Wu1,2.
Abstract
Introduction: Chronic stress plays an important role in the development of type 2 diabetes (T2D). Circular RNAs (circRNAs) play significant roles in regulating the pathogenesis of diseases by regulating gene expression. The aim of the present study was to identify the association between hsa_circ_0111707 and stress-related T2D.Entities:
Keywords: biomarker; circRNA; neuroendocrine; stress response; type 2 diabetes
Mesh:
Substances:
Year: 2022 PMID: 35116004 PMCID: PMC8803902 DOI: 10.3389/fendo.2021.790591
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555
Figure 1The flowchart of study design. T2D, type 2 diabetes; IFG, impaired fasting glucose; COPSOQ, Copenhagen Psychosocial Questionnaire; HOMA-IR, homeostasis model assessment of insulin resistance; RR, relative risk; AUC, area under the curve; HEK, human embryonic kidney; HSkMM, human skeletal muscle myoblasts.
Demographic and clinical characteristics of study participants in the first part of the study.
| Variable | T2D ( | IFG ( | Control ( |
|
|---|---|---|---|---|
| Age (years) | 54.91 ± 7.46 | 54.08 ± 7.77 | 53.97 ± 8.13 | 0.651 |
| Gender (male/female) | 60/55 | 55/49 | 55/50 | 0.994 |
| BMI (kg/m2) | 27.00 ± 3.05 | 26.64 ± 3.15 | 23.89 ± 3.12 | <0.001 |
| WC (cm) | 89.29 ± 8.56 | 86.95 ± 9.44 | 82.06 ± 9.71 | <0.001 |
| SBP (mmHg) | 133.01 ± 16.55d,e | 128.07 ± 18.61 | 124.04 ± 17.09 | 0.001 |
| DBP (mmHg) | 82.24 ± 10.74d,e | 79.00 ± 9.95 | 76.33 ± 9.66 | <0.001 |
| TCH (mmol/L) | 5.29 ± 0.93d,e | 4.98 ± 1.06 | 4.84 ± 0.94 | 0.003 |
| TG (mmol/L) | 2.39 ± 1.64f,g | 1.93 ± 1.21 | 1.62 ± 1.38 | <0.001 |
| LDLC (mmol/L) | 3.21 ± 0.91f,g | 2.92 ± 0.74 | 2.83 ± 0.56 | 0.001 |
| HDLC (mmol/L) | 1.48 ± 0.37 | 1.51 ± 0.26 | 1.57 ± 0.28 | 0.001 |
| FPG (mmol/L) | 9.26 ± 2.30f,g | 6.49 ± 0.25 | 4.97 ± 0.40 | <0.001 |
| HbA1c (%) | 7.51 ± 1.40f,g | 5.74 ± 0.60 | 5.20 ± 0.42 | <0.001 |
| Insulin (uIU/ml) | 15.01 ± 2.83f,g | 12.79 ± 2.51 | 10.07 ± 2.95 | <0.001 |
| HOMA-IR | 6.18 ± 1.79d,e | 3.67 ± 0.77 | 2.23 ± 0.71 | <0.001 |
| Cortisol (ng/ml) | 213.85 ± 39.14 | 202.72 ± 35.74 | 174.44 ± 31.27 | <0.001 |
| Smoking ( | 18, 15.65 | 16, 15.38 | 11, 10.48 | 0.469 |
| Alcohol use ( | 12, 10.43 | 13, 12.50 | 8, 7.62 | 0.503 |
| Physical activity ( | 83, 72.17 | 74, 71.15 | 85, 80.95 | 0.197 |
T2D, type 2 diabetes; IFG, impaired fasting glucose; BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; TCH, total cholesterol; TG, triglyceride; LDLC, low-density lipoprotein cholesterol; HDLC, high-density lipoprotein cholesterol; FPG, fast plasma glucose; HbA1c, glycated haemoglobin; HOMA-IR, homeostasis model assessment of insulin.
One-way ANOVA.
Chi-square test.
Kruskal-Wallis H test.
Significantly different from control group (p < 0.05 with LSD test).
Significantly different from IFG group (p< 0.05 with LSD test).
Significantly different from control group (p < 0.05 with Mann-Whitney U test).
Significantly different from IFG group (p < 0.05 with Mann-Whitney U test).
Association between COPSOQ variables and T2D.
| Variables | T2D group | IFG group | Control |
|
|---|---|---|---|---|
|
| 57.54 ± 19.20 | 55.01 ± 13.87 | 49.01 ± 18.91 | 0.001 |
| Work organization and content | 62.43 ± 17.79 | 62.02 ± 16.55 | 60.24 ± 16.05 | 0.597 |
| Interpersonal relations and leadership | 58.33 ± 17.65 | 62.28 ± 20.23 | 60.57 ± 18.37 | 0.293 |
|
| 56.74 ± 41.67 | 52.40 ± 40.10 | 39.29 ± 41.15 | 0.005 |
| Job satisfaction | 59.08 ± 20.72 | 59.68 ± 23.16 | 61.31 ± 21.25 | 0.736 |
COPSOQ, Copenhagen Psychosocial Questionnaire; T2D, type 2 diabetes; IFG, impaired fasting glucose.
*One-way ANOVA.
Significantly different from control group (p < 0.05).
Figure 2Relative expression of hsa_circ_0111707, miR-144-3p, and NR3C1 and Spearman’s correlation between hsa_circ_0111707 and miR-144-3p, NR3C1, and cortisol concentration. (A–C) Comparison between T2D, IFG, and control groups. (D–F) Spearman’s correlation between relative expression of hsa_circ_0111707 and miR-144-3p, NR3C1, and cortisol concentration in all the subjects. (G–I) Spearman’s correlation between relative expression of hsa_circ_0111707 and miR-144-3p, NR3C1, and cortisol concentration in subgroups. T2D, type 2 diabetes; IFG, impaired fasting glucose. * p < 0.05, ** p < 0.01, *** p < 0.001.
Spearman’s correlation matrix of hsa_circ_ 0111707 expression and COPSOQ variables.
| Scales | 1. | 2. | 3. | 4. | 5. | 6. | 7 |
|---|---|---|---|---|---|---|---|
| 1. | 1.00 | ||||||
| 2. Cortisol | 0.39* | 1.00 | |||||
| 3. | −0.23* | 0.21* | 1.00 | ||||
| 4. Work organization and content | −0.04 | 0.04 | −0.10 | 1.00 | |||
| 5. Interpersonal relations and leadership | 0.10 | −0.04 | −0.14* | 0.47* | 1.00 | ||
| 6. | −0.13* | 0.16* | 0.43* | 0.03 | −0.03 | 1.00 | |
| 7. Job satisfaction | 0.13* | −0.08 | −0.24* | 0.45* | 0.55* | −0.13* | 1.00 |
COPSOQ, Copenhagen Psychosocial Questionnaire.
*p < 0.05.
Figure 3The association between relative expression of hsa_circ_0111707 assessed by univariate and multiple logistic regression analyses. Model 1: adjusted for smoking, drinking, and physical activity. Model 2: further adjusted for BMI based on model 1. Model 3: further adjusted for TC, TG, HDLC, LDLC, SBP, and DBP based on model 2. RR, relative risk; CI, confidence interval; T2D, type 2 diabetes; IFG, impaired fasting glucose.
Figure 4hsa_circ_0111707 functions as a sponge for miR-144-3p. (A) The binding sites of hsa_circ_0111707 and miR-144-3p. (B) Luciferase assays revealed that miR-144-3p is a miRNA target of hsa_circ_0111707 in HEK293T. (C, D) Anti-AGO2 RIP was executed in HSkMM cells after transfection with miR-144-3p mimic or miR-NC, followed by qRT-PCR to detect the enrichment (expression) of hsa_circ_0111707 and miR-144-3p, respectively. HEK, human embryonic kidney; HSkMM, human skeletal muscle myoblasts; WT, wild type; MUT, mutant; Blank: empty plasma; Input: blank control. *** p < 0.001. ns, not significant.